²Î¿¼ÎÄÏ×/References:
[1] MACEDO F,LADEIRA K,PINHO F,et al.Bone metastases:an overview[J].Oncol Rev,2017,11(1):321.
[2] CENGIZ A,G?KSEL S,Y?REKLI Y.Diagnostic value of 18F-FDG PET/CT in patients with carcinoma of unknown primary[J].Mol Imaging Radionucl Ther,2018,27(3):126-132.
[3] BUDAK E,YANARATE?ÿðþ?‰C? A.Role of(18)F-FDG PET/CT in the detection of primary malignancy in patients with bone metastasis of unknown origin[J].Rev Esp Med Nucl Imagen Mol,2020,39(1):14-19.
[4] BURGLIN SA,HESS S,H?ILUND-CARLSEN PF,et al.18F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary:a systematic review and meta-analysis[J].Medicine(Baltimore),2017,96(16):e6713.
[5] ÖìÑÞ·¼,лÐÂÁ¢,ÓÚÑÞϼ,µÈ.18F-FDG PET/CTÏÔÏñSUVmax¶Ô²»Í¬²¡Àí·ÖÐÍÉöϸ°û°©µÄ¼ø±ð¼ÛÖµ[J].Ö£ÖÝ´óѧѧ±¨(ҽѧ°æ),2018,53(6):807-811.
[6] RIAZ S,NAWAZ M K,FARUQUI Z S,et al.Diagnostic accuracy of 18F-Fluorodeoxyglucose positron emission tomography-computed tomography in the evaluation of carcinoma of unknown primary[J].Mol Imaging Radionucl Ther,2016,25(1):11-18.
[7] TAMAM C,TAMAM M,MULAZIMOGLU M.The accuracy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of bone lesions of undetermined origin[J].World J Nucl Med,2016,15(2):124-129.
[8] TAKAGI T,KATAGIRI H,KIM Y,et al.Skeletal metastasis of unknown primary origin at the initial visit:a retrospective analysis of 286 cases[J].PLoS One,2015,10(6):e0129428.
[9] KWEE T C,BASU S,ALAVI A.PET and PET/CT for unknown primary tumors[J].Methods Mol Biol,2011,727:317-333.
[10] ÆëºìÑÞ,ËïÑ·,°²Èñ.¹Ç×ªÒÆÁöÓ°Ïñѧ¼ì²é·½·¨¼°Ïà¹Ø½øÕ¹[J].»ªÖпƼ¼´óѧѧ±¨(ҽѧ°æ),2015(1):121-124.
[11] ÄßÊÀ¼Ò.¹Ç×ªÒÆÁö18F-FDG PET/CT SUVmaxÓëÆä´óС¼°×é֯ѧÀàÐ͵ÄÏà¹ØÐÔÑо¿[D].´óÁ¬:´óÁ¬Ò½¿Æ´óѧ,2018.
[12] ÀîÔ¶,Å£Ïþ»Ô,Ð캣ÈÙ.18F-FDG PET/CTÏÔÏñÔÚ¹Ç×ªÒÆ°©Õï¶ÏÖеÄÓ¦ÓÃ[J].ɽ¶«Ò½Ò©,2011,51(40):14-16.
[13] YUN M J.Imaging of gastric cancer metabolism using 18F-FDG PET/CT[J].J Gastric Cancer,2014,14(1):1-6.
[14] SON G M,KIM S J.Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake:a systematic review and meta-analysis[J].Abdom Radiol(NY),2019,44(2):456-463.
[15] WU D,HU Y,WEI Q,et al.Three primary carcinomas on 18F-FDG PET/CT:intrahepatic cholangiocarcinoma,papillary renal cell carcinoma,and clear cell renal cell carcinoma[J].Clin Nucl Med,2018,43(6):428-430.
[16] PARK S B,PARK J M,MOON S H,et al.Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis[J].PLoS One,2018,13(5):e0196808.
[17] ³ÂÆÐÜ¿,ÍõÑ©¾é,ÑîÖ¾.18F-FDG PET/CTÏÔÏñ¶Ô¿ÉÒɼ××´ÏÙÔ·¢²¡±äµÄÆÀ¹À¼ÛÖµ[J].±ê¼ÇÃâÒß·ÖÎöÓëÁÙ´²,2014,21(1):45-49.
[18] ¶ÃϽÜ,ÁÖÏéͨ,ÕÔ¾ü,µÈ.17Àý¶ñÐÔÖ×Áö18·úÍÑÑõÆÏÌÑÌÇPETÏÔÏñ¼ÙÒõÐԵķÖÎö[J].ÖлªÖ×ÁöÔÓÖ¾,2006,28(9):713-717.
[19] FRAUM T J,LUDWIG D R,KIM E H,et al.Prostate cancer PET tracers:essentials for the urologist[J].Can J Urol,2018,25(4):9371-9383.
[20] SHARMA A,METE U K,SOOD A,et al.Utility of early dynamic and delayed post-diuretic(18)F-FDG PET/CT SUV(max)in predicting tumour grade and T-stage of urinary bladder carcinoma:results from a prospective single centre study[J].Br J Radiol,2017,90(172):20160787.